N
2.82
-0.07 (-2.42%)
| Penutupan Terdahulu | 2.89 |
| Buka | 2.89 |
| Jumlah Dagangan | 170,176 |
| Purata Dagangan (3B) | 244,401 |
| Modal Pasaran | 356,180,416 |
| Harga / Buku (P/B) | 0.610 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 26 Feb 2026 |
| EPS Cair (TTM) | -0.540 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 15.09% |
| Nisbah Semasa (MRQ) | 17.36 |
| Aliran Tunai Operasi (OCF TTM) | -56.82 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -34.19 M |
| Pulangan Atas Aset (ROA TTM) | -19.06% |
| Pulangan Atas Ekuiti (ROE TTM) | -30.93% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | Nautilus Biotechnology, Inc. | Menaik | Menaik |
AISkor Stockmoo
0.4
| Konsensus Penganalisis | 2.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -5.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 2.0 |
| Purata | 0.38 |
|
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 33.38% |
| % Dimiliki oleh Institusi | 48.76% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Madrona Venture Group, Llc | 31 Dec 2025 | 6,020,770 |
| Clarius Group, Llc | 31 Dec 2025 | 1,209,646 |
| Sentinel Trust Co Lba | 31 Dec 2025 | 750,000 |
| Tikvah Management Llc | 31 Dec 2025 | 726,895 |
| Julat 52 Minggu | ||
| Median | 4.00 (41.84%) | |
| Jumlah | 1 Beli | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Guggenheim | 27 Feb 2026 | 4.00 (41.84%) | Beli | 2.82 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |